Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia

Mohamed El Missiry; Shady Adnan Awad; Hanna Laura Maria Koskela; Ahmed Al-Samadi; Marja Ekblom; Berit Markevan; Ingbritt Astrand-Grundstrom; Maren Wold; Ellen Rabben Svedahl; Birgitte Ravn Juhl; Ole Weis Bjerrum; Inger Haulin; Kimmo Porkka; Ulla Olsson-Stromberg; Henrik Hjorth-Hansen; Satu Mustjoki

doi:10.1007/s00432-015-2101-4

Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia

Mohamed El Missiry, Shady Adnan Awad, Hanna Laura Maria Koskela, Ahmed Al-Samadi, Marja Ekblom, Berit Markevan, Ingbritt Astrand-Grundstrom, Maren Wold, Ellen Rabben Svedahl, Birgitte Ravn Juhl, Ole Weis Bjerrum, Inger Haulin, Kimmo Porkka, Ulla Olsson-Stromberg, Henrik Hjorth-Hansen, Satu Mustjoki

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Journal of Cancer Research and Clinical Oncology
Volume	142
Issue number	5
Pages (from-to)	1041-1050
Number of pages	10
ISSN	0171-5216
DOIs	https://doi.org/10.1007/s00432-015-2101-4
Publication status	Published - May 2016
MoE publication type	A1 Journal article-refereed

Fields of Science

Bone marrow
Lymphocyte
CML
Tyrosine kinase inhibitor
Therapy response
LARGE GRANULAR LYMPHOCYTOSIS
DASATINIB THERAPY
NATURAL-KILLER
T-LYMPHOCYTES
CHRONIC-PHASE
CML PATIENTS
IN-VITRO
NK-CELLS
IMATINIB
PROLIFERATION
3122 Cancers

Access to Document

10.1007/s00432-015-2101-4

Assessment of bone marrow lymphocytic statusFinal published version, 999 KB

Cite this

El Missiry, M., Awad, S. A., Koskela, H. L. M., Al-Samadi, A., Ekblom, M., Markevan, B., Astrand-Grundstrom, I., Wold, M., Svedahl, E. R., Juhl, B. R., Bjerrum, O. W., Haulin, I., Porkka, K., Olsson-Stromberg, U., Hjorth-Hansen, H., & Mustjoki, S. (2016). Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. Journal of Cancer Research and Clinical Oncology, 142(5), 1041-1050. https://doi.org/10.1007/s00432-015-2101-4

@article{6c95ed8500e446aeb521b19da81facfe,

title = "Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia",

keywords = "Bone marrow, Lymphocyte, CML, Tyrosine kinase inhibitor, Therapy response, LARGE GRANULAR LYMPHOCYTOSIS, DASATINIB THERAPY, NATURAL-KILLER, T-LYMPHOCYTES, CHRONIC-PHASE, CML PATIENTS, IN-VITRO, NK-CELLS, IMATINIB, PROLIFERATION, 3122 Cancers",

author = "{El Missiry}, Mohamed and Awad, {Shady Adnan} and Koskela, {Hanna Laura Maria} and Ahmed Al-Samadi and Marja Ekblom and Berit Markevan and Ingbritt Astrand-Grundstrom and Maren Wold and Svedahl, {Ellen Rabben} and Juhl, {Birgitte Ravn} and Bjerrum, {Ole Weis} and Inger Haulin and Kimmo Porkka and Ulla Olsson-Stromberg and Henrik Hjorth-Hansen and Satu Mustjoki",

year = "2016",

month = may,

doi = "10.1007/s00432-015-2101-4",

language = "English",

volume = "142",

pages = "1041--1050",

journal = "Journal of Cancer Research and Clinical Oncology",

issn = "0171-5216",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "5",

}

El Missiry, M, Awad, SA, Koskela, HLM, Al-Samadi, A, Ekblom, M, Markevan, B, Astrand-Grundstrom, I, Wold, M, Svedahl, ER, Juhl, BR, Bjerrum, OW, Haulin, I, Porkka, K, Olsson-Stromberg, U, Hjorth-Hansen, H & Mustjoki, S 2016, 'Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia', Journal of Cancer Research and Clinical Oncology, vol. 142, no. 5, pp. 1041-1050. https://doi.org/10.1007/s00432-015-2101-4

Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. / El Missiry, Mohamed; Awad, Shady Adnan; Koskela, Hanna Laura Maria et al.
In: Journal of Cancer Research and Clinical Oncology, Vol. 142, No. 5, 05.2016, p. 1041-1050.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia

AU - El Missiry, Mohamed

AU - Awad, Shady Adnan

AU - Koskela, Hanna Laura Maria

AU - Al-Samadi, Ahmed

AU - Ekblom, Marja

AU - Markevan, Berit

AU - Astrand-Grundstrom, Ingbritt

AU - Wold, Maren

AU - Svedahl, Ellen Rabben

AU - Juhl, Birgitte Ravn

AU - Bjerrum, Ole Weis

AU - Haulin, Inger

AU - Porkka, Kimmo

AU - Olsson-Stromberg, Ulla

AU - Hjorth-Hansen, Henrik

AU - Mustjoki, Satu

PY - 2016/5

Y1 - 2016/5

KW - Bone marrow

KW - Lymphocyte

KW - CML

KW - Tyrosine kinase inhibitor

KW - Therapy response

KW - LARGE GRANULAR LYMPHOCYTOSIS

KW - DASATINIB THERAPY

KW - NATURAL-KILLER

KW - T-LYMPHOCYTES

KW - CHRONIC-PHASE

KW - CML PATIENTS

KW - IN-VITRO

KW - NK-CELLS

KW - IMATINIB

KW - PROLIFERATION

KW - 3122 Cancers

U2 - 10.1007/s00432-015-2101-4

DO - 10.1007/s00432-015-2101-4

M3 - Article

SN - 0171-5216

VL - 142

SP - 1041

EP - 1050

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

IS - 5

ER -